Skip to content

SPRINGWORKS THERAPEUTICS, INC.

CIK 0001773427

← back to feed
Revenue (TTM)
$109.03M
+3,417.3% YoY Q1 May 2025
Net Income (TTM)
−$264.02M
+20.6% YoY Q1 May 2025
EPS Diluted (TTM)
−$3.55
+32.4% YoY Q1 May 2025
Gross Margin
90.3%
Q1 May 2025
Operating Margin
-254.3%
Q1 May 2025
Net Margin
-242.1%
Q1 May 2025
Free Cash Flow (TTM)
−$264.17M
Q1 May 2025
Cash
$63.77M
Q1 May 2025
Total Debt
—
Q1 May 2025
Shares Outstanding
75.32M sh
Q1 May 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings